Status:
COMPLETED
The Utility of the Validated Intraoperative Bleeding Scale in Spine Surgery
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Intraoperative Blood Loss
Thoracolumbar Spine Surgery
Eligibility:
All Genders
18-88 years
Brief Summary
This is a single-center, prospective, observational study that will compare the blood transfusion rate between intraoperative bleeding severity characterized using the Validated Intraoperative Bleedin...
Detailed Description
Primary Aim: Assess the association between the VIBe scale and intraoperative and postoperative blood transfusion rates for posterior thoracolumbar spine surgery. Primary Hypothesis: Patients with hi...
Eligibility Criteria
Inclusion
- Ages 18 to 88 years
- Patients receiving elective open, posterior thoracolumbar surgery
Exclusion
- Patients receiving non-elective or trauma surgery
- Patients with pathologic spine fracture or metastatic disease to the spine
- Patients receiving thoracolumbar surgery through anterior or lateral approach
- Patients receiving spine surgery for debridement of suspected or confirmed infection
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 14 2023
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT05258487
Start Date
March 1 2022
End Date
March 14 2023
Last Update
May 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Medical Center
Baltimore, Maryland, United States, 21201